MedTrace Logo

Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization

NCT02287701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-08-14

No results posted yet for this study

Summary

The overarching goal of this project is to explore whether associations exist between metrics obtained from PET/MRI incorporating advanced MRI sequences and features of bladder cancer, including grade, stage, and treatment response.

Conditions

Interventions

PROCEDURE

PET/MRI

Simultaneous PET/MRI (3T system)

Sponsors & Collaborators

Principal Investigators

  • Andrew Rosenkrantz, MD · NYU School of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287701 on ClinicalTrials.gov